Cardinal Spine cervical vertebral body replacement device receives FDA 510(k) clearance


PaxMed International has announced that it has been granted US Food and Drug Administration (FDA) 510(k) clearance to market the Cardinal Spine C-VBR (cervical vertebral body replacement).

According to a press release, the C-VBR is only the second cervical vertebral body replacement device to be cleared by the FDA. It is designed to eliminate the possibility of postoperative height reduction.

This clearance on behalf of Cardinal Spine marks the 180th 510(k) submission clearance for PaxMed.

(Visited 211 times, 1 visits today)